콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

Here's Why You Should Retain OPK Stock in Your Portfolio for Now

요약

OPKO Health leans on RAYALDEE and key partnerships, such as BioReference and 4Kscore, as it ramps toward mid-2026 diagnostics breakeven.